GIM
SMED

Granahan Investment Management’s Sharps Compliance Corp SMED Stock Holding History

Granahan Investment Management’s Portfolio SMED Stock Details SMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-471,437
Closed -$1.38M – 185
2022
Q2 		$1.38M Sell
471,437
-246,764
-34% -$1.03M 0.05% 162
2022
Q1 		$4.24M Sell
718,201
-136,384
-16% -$857K 0.11% 142
2021
Q4 		$6.09M Buy
854,585
+103,531
+14% +$795K 0.13% 140
2021
Q3 		$6.21M Buy
751,054
+41,897
+6% +$390K 0.12% 137
2021
Q2 		$7.3M Sell
709,157
-46,535
-6% -$648K 0.14% 136
2021
Q1 		$10.9M Buy
755,692
+143,724
+23% +$1.85M 0.23% 87
2020
Q4 		$5.78M Buy
611,968
+265,228
+76% +$2.03M 0.13% 122
2020
Q3 		$2.17M Buy
+346,740
New +$2.52M 0.07% 148

Granahan Investment Management's SMED Position: Q3 2022 in Review

Granahan Investment Management sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 471,437 shares — an estimated $1.38M sold.

Granahan Investment Management first reported a position in SMED in Q3 2020 and held it in 8 quarters. The position peaked at $10.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.

  • Granahan Investment Management reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
  • Granahan Investment Management sold 471,437 Sharps Compliance Corp shares in Q3 2022, an estimated $1.38M.
  • Granahan Investment Management first reported a position in Sharps Compliance Corp in Q3 2020 and held it in 8 quarters.
  • Granahan Investment Management's Sharps Compliance Corp position peaked at $10.9M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.

Based on Granahan Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.